Roche Holding AG
SIX:ROG

Watchlist Manager
Roche Holding AG Logo
Roche Holding AG
SIX:ROG
Watchlist
Price: 316.8 CHF -0.35% Market Closed
Market Cap: 256.4B CHF

Relative Value

The Relative Value of one ROG stock under the Base Case scenario is hidden CHF. Compared to the current market price of 316.8 CHF, Roche Holding AG is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ROG Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
23
vs Industry
30
Median 3Y
3.5
Median 5Y
3.8
Industry
2.6
Forward
4
vs History
4
vs Industry
22
Median 3Y
19.2
Median 5Y
18.8
Industry
21.6
Forward
15.7
vs History
25
vs Industry
28
Median 3Y
11.7
Median 5Y
12.4
Industry
16.5
vs History
41
vs Industry
19
Median 3Y
13.5
Median 5Y
15.6
Industry
22.5
vs History
19
vs Industry
7
Median 3Y
7.3
Median 5Y
7.5
Industry
2.3
vs History
15
vs Industry
27
Median 3Y
3.8
Median 5Y
4
Industry
2.9
Forward
4.4
vs History
20
vs Industry
34
Median 3Y
5.1
Median 5Y
5.5
Industry
5.5
vs History
19
vs Industry
29
Median 3Y
9.8
Median 5Y
10.3
Industry
13
Forward
11.3
vs History
20
vs Industry
30
Median 3Y
11.7
Median 5Y
12.3
Industry
16.6
Forward
13.1
vs History
14
vs Industry
27
Median 3Y
12.6
Median 5Y
13
Industry
15.8
vs History
6
vs Industry
10
Median 3Y
17.6
Median 5Y
17.9
Industry
19.1
vs History
42
vs Industry
22
Median 3Y
2.9
Median 5Y
3.2
Industry
1.9

Multiples Across Competitors

ROG Competitors Multiples
Roche Holding AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Roche Holding AG
SIX:ROG
252.3B CHF 4.1 26.8 11.5 13.4
US
Eli Lilly and Co
NYSE:LLY
971.9B USD 16.4 52.8 35.5 38
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
509.1B USD 5.5 20.3 16.6 21.5
UK
AstraZeneca PLC
LSE:AZN
208.5B GBP 4.8 29.7 108 158
CH
Novartis AG
SIX:NOVN
202.4B CHF 4.5 17.7 11.2 14.5
US
Merck & Co Inc
NYSE:MRK
249.5B USD 3.9 13.1 9.3 11.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.5 13.7 9.6 11.2
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
147B USD 2.3 15 7.6 10.4
FR
Sanofi SA
PAR:SAN
101.4B EUR 1.5 7.3 6.7 6.7
P/E Multiple
Earnings Growth PEG
CH
Roche Holding AG
SIX:ROG
Average P/E: 21.8
26.8
29%
0.9
US
Eli Lilly and Co
NYSE:LLY
52.8
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.3
29%
0.7
UK
AstraZeneca PLC
LSE:AZN
29.7
38%
0.8
CH
Novartis AG
SIX:NOVN
17.7
17%
1
US
Merck & Co Inc
NYSE:MRK
13.1
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.7
4%
3.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
15
29%
0.5
FR
Sanofi SA
PAR:SAN
7.3
26%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CH
Roche Holding AG
SIX:ROG
Average EV/EBITDA: 399.4
11.5
4%
2.9
US
Eli Lilly and Co
NYSE:LLY
35.5
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.6
9%
1.8
UK
AstraZeneca PLC
LSE:AZN
108
10%
10.8
CH
Novartis AG
SIX:NOVN
11.2
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.3
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.6
2%
4.8
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
1%
7.6
FR
Sanofi SA
PAR:SAN
6.7
8%
0.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CH
Roche Holding AG
SIX:ROG
Average EV/EBIT: 1 710.7
13.4
5%
2.7
US
Eli Lilly and Co
NYSE:LLY
38
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.5
15%
1.4
UK
AstraZeneca PLC
LSE:AZN
158
23%
6.9
CH
Novartis AG
SIX:NOVN
14.5
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.1
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11.2
1%
11.2
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.4
8%
1.3
FR
Sanofi SA
PAR:SAN
6.7
15%
0.4